[The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
The materials of observation over 231 patients with highly differentiated thyroid cancer were used to define indications for 131I-therapy, to specify course and summary doses taking into account side-effects of 131I. 131I-therapy is an effective method in multimodality therapy of highly differentiated thyroid cancer.